XML 53 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Fair Value Disclosures [Abstract]    
Schedule of Liabilities Measured on a Recurring Basis
The following tables summarize the Company’s liabilities that are measured at fair value on a recurring basis (in thousands):
 
 
 
Fair Value Measurement at Reporting Date Using
 
March 31, 2020
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs (Level 3)
Liabilities:
 
 
 
 
 
 
 
Contingent consideration
$
12,162

 
$

 
$

 
$
12,162

 
 
 
Fair Value Measurement at Reporting Date Using
 
December 31, 2019
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs (Level 3)
Liabilities:
 
 
 
 
 
 
 
Contingent consideration
$
17,327

 
$

 
$

 
$
17,327


The following tables summarize the Company’s liabilities that are measured at fair value on a recurring basis (in thousands):
 
 
 
Fair Value Measurement at Reporting Date Using
 
December 31, 2019
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Significant Unobservable Inputs (Level 3)
Liabilities:
 
 
 
 
 
 
 
Contingent consideration
$
17,327

 
$

 
$

 
$
17,327

 
 
 
Fair Value Measurement at Reporting Date Using
 
December 31, 2018
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Significant Unobservable Inputs (Level 3)
Liabilities:
 
 
 
 
 
 
 
Contingent consideration
$
6,782

 
$

 
$

 
$
6,782


Schedule of Changes in Level 3 Instruments  
The following table provides a roll-forward of the fair value of recurring Level 3 fair value measurements for the years ended December 31, 2019, 2018 and 2017 (in thousands):
 
2019
 
2018
 
2017
Liabilities:
 
 
 
 
 
Contingent consideration:
 
 
 
 
 
Beginning of year balance
$
6,782

 
$
785

 
$
190

Issuance of contingent consideration in connection with acquisitions
7,216

 
5,350

 
595

Payment of contingent consideration
(1,658
)
 
(387
)
 

Additional accruals included in earnings
4,987

 
1,034

 

Ending balance
$
17,327

 
$
6,782

 
$
785